195 related articles for article (PubMed ID: 2249339)
1. Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
Koh EH; Buzdar AU; Ames FC; Singletary SE; McNeese MD; Frye D; Holmes FA; Fraschini G; Hug V; Theriault RL
Cancer Chemother Pharmacol; 1990; 27(2):94-100. PubMed ID: 2249339
[TBL] [Abstract][Full Text] [Related]
2. Management of inflammatory carcinoma of the breast. A combined modality approach.
Fastenberg NA; Martin RG; Buzdar AU; Hortobagyi GN; Montague ED; Blumenschein GR; Jessup JM
Am J Clin Oncol; 1985 Apr; 8(2):134-41. PubMed ID: 3841746
[TBL] [Abstract][Full Text] [Related]
3. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
Ueno NT; Buzdar AU; Singletary SE; Ames FC; McNeese MD; Holmes FA; Theriault RL; Strom EA; Wasaff BJ; Asmar L; Frye D; Hortobagyi GN
Cancer Chemother Pharmacol; 1997; 40(4):321-9. PubMed ID: 9225950
[TBL] [Abstract][Full Text] [Related]
4. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
[TBL] [Abstract][Full Text] [Related]
6. Multimodal treatment for inflammatory breast cancer.
Thoms WW; McNeese MD; Fletcher GH; Buzdar AU; Singletary SE; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):739-45. PubMed ID: 2487034
[TBL] [Abstract][Full Text] [Related]
7. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation.
Brun B; Otmezguine Y; Feuilhade F; Julien M; Lebourgeois JP; Calitchi E; Roucayrol AM; Ganem G; Huart J; Pierquin B
Cancer; 1988 Mar; 61(6):1096-103. PubMed ID: 3342369
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory carcinoma of the breast: treatment results on 107 patients.
Fields JN; Perez CA; Kuske RR; Fineberg BB; Bartlett N
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):249-55. PubMed ID: 2753755
[TBL] [Abstract][Full Text] [Related]
9. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results.
Colozza M; Gori S; Mosconi AM; Anastasi P; de Angelis V; Giansanti M; Mercati U; Aristei C; Latini P; Tonato M
Am J Clin Oncol; 1996 Feb; 19(1):10-7. PubMed ID: 8554028
[TBL] [Abstract][Full Text] [Related]
11. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
[TBL] [Abstract][Full Text] [Related]
12. Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation.
Arthur DW; Schmidt-Ullrich RK; Friedman RB; Wazer DE; Kachnic LA; Amir C; Bear HD; Hackney MH; Smith TJ; Lawrence W
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):289-96. PubMed ID: 10760421
[TBL] [Abstract][Full Text] [Related]
13. First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
Viens P; Palangié T; Janvier M; Fabbro M; Roché H; Delozier T; Labat JP; Linassier C; Audhuy B; Feuilhade F; Costa B; Delva R; Cure H; Rousseau F; Guillot A; Mousseau M; Ferrero JM; Bardou VJ; Jacquemier J; Pouillart P
Br J Cancer; 1999 Oct; 81(3):449-56. PubMed ID: 10507769
[TBL] [Abstract][Full Text] [Related]
14. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
[TBL] [Abstract][Full Text] [Related]
15. The management of locally advanced breast cancer: a combined modality approach.
Kantarjian HM; Hortobagyi GN; Smith TL; Blumenschein GR; Montague E; Buzdar AU; Martin RG
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1353-61. PubMed ID: 6548710
[TBL] [Abstract][Full Text] [Related]
16. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors.
Rouëssé J; Friedman S; Mouriesse H; Sarrazin D; Spielmann M
Breast Cancer Res Treat; 1990 Jul; 16(1):15-22. PubMed ID: 2207344
[TBL] [Abstract][Full Text] [Related]
19. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Hortobagyi GN; Ames FC; Buzdar AU; Kau SW; McNeese MD; Paulus D; Hug V; Holmes FA; Romsdahl MM; Fraschini G
Cancer; 1988 Dec; 62(12):2507-16. PubMed ID: 3056604
[TBL] [Abstract][Full Text] [Related]
20. Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Harris EE; Schultz D; Bertsch H; Fox K; Glick J; Solin LJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1200-8. PubMed ID: 12654428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
